{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:21:40Z","timestamp":1788391300836,"version":"build-2803163510"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1007\/s13555-023-01032-9","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T13:02:08Z","timestamp":1696424528000},"page":"2797-2815","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Navigating the Multidimensional Impact of Living with Hidradenitis Suppurativa: An In-Depth Netnographic Study on Social Media Platforms"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6020-6356","authenticated-orcid":false,"given":"Ericles Andrei","family":"Bellei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Vicente Esteves","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz Magalh\u00e3es","family":"Eng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Tozato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo Hamilko","family":"de Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika Yumi","family":"Tamashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gleison Vieira","family":"Duarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Toledo Rodrigues","family":"de F\u00e1tima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Ferreira","family":"Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto Souto","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagner Guimar\u00e3es Galv\u00e3o","family":"Cesar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Garutti","family":"Thies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"1032_CR1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/jdv.12567","volume":"29","author":"E Shavit","year":"2014","unstructured":"Shavit E, Dreiher J, Freud T, Halevy S, Vinker S, Cohen AD. Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2014;29:371\u20136. https:\/\/doi.org\/10.1111\/jdv.12567.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1032_CR2","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1159\/000453259","volume":"232","author":"R Vangipuram","year":"2016","unstructured":"Vangipuram R, Vaidya T, Jandarov R, Alikhan A. Factors contributing to depression and chronic pain in patients with hidradenitis suppurativa: results from a single-center retrospective review. Dermatology. 2016;232:692\u20135. https:\/\/doi.org\/10.1159\/000453259.","journal-title":"Dermatology"},{"key":"1032_CR3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jid.2017.09.008","volume":"138","author":"L Thorlacius","year":"2018","unstructured":"Thorlacius L, Cohen AD, Gislason GH, Jemec GBE, Egeberg A. Increased suicide risk in patients with hidradenitis suppurativa. J Investig Dermatol. 2018;138:52\u20137. https:\/\/doi.org\/10.1016\/j.jid.2017.09.008.","journal-title":"J Investig Dermatol"},{"key":"1032_CR4","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.clindermatol.2020.10.016","volume":"39","author":"S Garcovich","year":"2021","unstructured":"Garcovich S, Genovese G, Moltrasio C, Malvaso D, Marzano AV. PASH, PAPASH, PsAPASH, and PASS: the autoinflammatory syndromes of hidradenitis suppurativa. Clin Dermatol. 2021;39:240\u20137. https:\/\/doi.org\/10.1016\/j.clindermatol.2020.10.016.","journal-title":"Clin Dermatol"},{"key":"1032_CR5","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.3390\/biomedicines10082039","volume":"10","author":"C Moltrasio","year":"2022","unstructured":"Moltrasio C, Tricarico PM, Romagnuolo M, Marzano AV, Crovella S. Hidradenitis suppurativa: a perspective on genetic factors involved in the disease. Biomedicines. 2022;10:2039. https:\/\/doi.org\/10.3390\/biomedicines10082039.","journal-title":"Biomedicines"},{"key":"1032_CR6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1600-0625.2008.00712.x","volume":"17","author":"LR Paus","year":"2008","unstructured":"Paus LR, Kurzen H, Kurokawa I, et al. What causes hidradenitis suppurativa? Exp Dermatol. 2008;17:455\u201372. https:\/\/doi.org\/10.1111\/j.1600-0625.2008.00712.x.","journal-title":"Exp Dermatol"},{"key":"1032_CR7","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jaad.2019.02.067","volume":"81","author":"A Alikhan","year":"2019","unstructured":"Alikhan A, Sayed C, Alavi A, et al. North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa foundations. J Am Acad Dermatol. 2019;81:76\u201390. https:\/\/doi.org\/10.1016\/j.jaad.2019.02.067.","journal-title":"J Am Acad Dermatol"},{"key":"1032_CR8","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/ijd.13937","volume":"57","author":"M Ianhez","year":"2018","unstructured":"Ianhez M, Schmitt JV, Miot HA. Prevalence of hidradenitis suppurativa in Brazil: a population survey. Int J Dermatol. 2018;57:618\u201320. https:\/\/doi.org\/10.1111\/ijd.13937.","journal-title":"Int J Dermatol"},{"key":"1032_CR9","doi-asserted-by":"publisher","first-page":"6709","DOI":"10.3390\/ijerph18136709","volume":"18","author":"T Montero-Vilchez","year":"2021","unstructured":"Montero-Vilchez T, Diaz-Calvillo P, Rodriguez-Pozo J-A, et al. The burden of hidradenitis suppurativa signs and symptoms in quality of life: systematic review and meta-analysis. Int J Environ Res Public Health. 2021;18:6709. https:\/\/doi.org\/10.3390\/ijerph18136709.","journal-title":"Int J Environ Res Public Health"},{"key":"1032_CR10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2340\/00015555-0866","volume":"90","author":"\u0141 Matusiak","year":"2010","unstructured":"Matusiak \u0141, Bieniek A, Szepietowski J. Psychophysical aspects of hidradenitis suppurativa. Acta Derm Venereol. 2010;90:264\u20138. https:\/\/doi.org\/10.2340\/00015555-0866.","journal-title":"Acta Derm Venereol"},{"key":"1032_CR11","doi-asserted-by":"publisher","first-page":"6131","DOI":"10.3390\/ijerph18116131","volume":"18","author":"PV Chernyshov","year":"2021","unstructured":"Chernyshov PV, Finlay AY, Tomas-Aragones L, et al. Quality of life in hidradenitis suppurativa: an update. Int J Environ Res Public Health. 2021;18:6131. https:\/\/doi.org\/10.3390\/ijerph18116131.","journal-title":"Int J Environ Res Public Health"},{"key":"1032_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1590\/abd1806-4841.20198607","volume":"94","author":"RF Magalh\u00e3es","year":"2019","unstructured":"Magalh\u00e3es RF, Rivitti-Machado MC, Duarte GV, et al. Consensus on the treatment of hidradenitis suppurativa - Brazilian Society of Dermatology. An Bras Dermatol. 2019;94:7\u201319. https:\/\/doi.org\/10.1590\/abd1806-4841.20198607.","journal-title":"An Bras Dermatol"},{"key":"1032_CR13","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.2147\/CCID.S420750","volume":"16","author":"EA Bellei","year":"2023","unstructured":"Bellei EA, Shirozaki MEM, Puglia ALP, et al. Requirements for Brazilian outpatient centers of excellence in hidradenitis suppurativa: consensus co-creative study. Clin Cosmet Investig Dermatol. 2023;16:2029\u201344. https:\/\/doi.org\/10.2147\/CCID.S420750.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"1032_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7573\/dic.2021-9-6","volume":"11","author":"MC Rivitti-Machado","year":"2022","unstructured":"Rivitti-Machado MC, Ferreira Magalh\u00e3es R, da Silva RS, et al. Therapies for hidradenitis suppurativa: a systematic review with a focus on Brazil. Drugs Context. 2022;11:1\u201310. https:\/\/doi.org\/10.7573\/dic.2021-9-6.","journal-title":"Drugs Context"},{"key":"1032_CR15","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1590\/abd1806-4841.20175588","volume":"92","author":"TCPC de Andrade","year":"2017","unstructured":"de Andrade TCPC, Vieira BC, Oliveira AMN, Martins TY, Santiago TM, Martelli ACC. Hidradenitis suppurativa: epidemiological study of cases diagnosed at a dermatological reference center in the city of Bauru, in the Brazilian southeast state of S\u00e3o Paulo, between 2005 and 2015. An Bras Dermatol. 2017;92:196\u20139. https:\/\/doi.org\/10.1590\/abd1806-4841.20175588.","journal-title":"An Bras Dermatol"},{"key":"1032_CR16","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.jval.2016.05.010","volume":"19","author":"B-WB Tai","year":"2016","unstructured":"Tai B-WB, Bae YH, Le QA. A systematic review of health economic evaluation studies using the patient\u2019s perspective. Value in Health. 2016;19:903\u20138. https:\/\/doi.org\/10.1016\/j.jval.2016.05.010.","journal-title":"Value in Health"},{"key":"1032_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/01445442-199705000-00012","volume":"19","author":"M Gerteis","year":"1997","unstructured":"Gerteis M, Edgman-Levitan S, Daley J, Delbanco TL. Through the patient\u02bcs eyes: understanding and promoting patient-centered care. J Healthc Qual. 1997;19:43. https:\/\/doi.org\/10.1097\/01445442-199705000-00012.","journal-title":"J Healthc Qual"},{"key":"1032_CR18","first-page":"1","volume-title":"Human-centered service design for healthcare transformation","author":"P Alafaireet","year":"2023","unstructured":"Alafaireet P, Diserens P. Bridging the health gap: human-centered approaches to connect clinical and community care. In: Human-centered service design for healthcare transformation. Springer; 2023. p. 1\u201319."},{"key":"1032_CR19","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1016\/j.jaad.2018.08.031","volume":"80","author":"NM Golbari","year":"2019","unstructured":"Golbari NM, Porter ML, Kimball AB. Online communications among hidradenitis suppurativa patients reflect community needs. J Am Acad Dermatol. 2019;80:1760\u20132. https:\/\/doi.org\/10.1016\/j.jaad.2018.08.031.","journal-title":"J Am Acad Dermatol"},{"key":"1032_CR20","volume-title":"Netnography","author":"R Kozinets","year":"2019","unstructured":"Kozinets R. Netnography. 3rd ed. London: SAGE; 2019.","edition":"3"},{"key":"1032_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1504\/IJTMKT.2016.075687","volume":"11","author":"M Bartl","year":"2016","unstructured":"Bartl M, Kannan VK, Stockinger H. A review and analysis of literature on netnography research. Int J Technol Mark. 2016;11:165. https:\/\/doi.org\/10.1504\/IJTMKT.2016.075687.","journal-title":"Int J Technol Mark"},{"key":"1032_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s13671-021-00343-4","volume":"10","author":"MD Szeto","year":"2021","unstructured":"Szeto MD, Mamo A, Afrin A, Militello M, Barber C. Social media in dermatology and an overview of popular social media platforms. Curr Dermatol Rep. 2021;10:97\u2013104. https:\/\/doi.org\/10.1007\/s13671-021-00343-4.","journal-title":"Curr Dermatol Rep"},{"key":"1032_CR23","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1111\/cup.13680","volume":"47","author":"J Saleh","year":"2020","unstructured":"Saleh J, Dahiya M. Social media trends in dermatology, dermatopathology, and pathology publications: the social construction of medical subdisciplines. J Cutan Pathol. 2020;47:601\u20135. https:\/\/doi.org\/10.1111\/cup.13680.","journal-title":"J Cutan Pathol"},{"key":"1032_CR24","doi-asserted-by":"publisher","first-page":"2738","DOI":"10.1080\/09546634.2022.2069661","volume":"33","author":"L Barrutia","year":"2022","unstructured":"Barrutia L, Vega-Guti\u00e9rrez J, Santamarina-Albertos A. Benefits, drawbacks, and challenges of social media use in dermatology: a systematic review. J Dermatol Treat. 2022;33:2738\u201357. https:\/\/doi.org\/10.1080\/09546634.2022.2069661.","journal-title":"J Dermatol Treat"},{"key":"1032_CR25","doi-asserted-by":"publisher","first-page":"e441","DOI":"10.3399\/bjgp18X696161","volume":"68","author":"R Elvey","year":"2018","unstructured":"Elvey R, Voorhees J, Bailey S, Burns T, Hodgson D. GPs\u2019 views of health policy changes: a qualitative \u2018netnography\u2019 study of UK general practice online magazine commentary. Br J Gen Pract. 2018;68:e441\u20138. https:\/\/doi.org\/10.3399\/bjgp18X696161.","journal-title":"Br J Gen Pract"},{"key":"1032_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1080\/09546634.2019.1621981","volume":"32","author":"AJ Hendricks","year":"2021","unstructured":"Hendricks AJ, Hirt PA, Sekhon S, et al. Non-pharmacologic approaches for hidradenitis suppurativa \u2013 a systematic review. J Dermatol Treat. 2021;32:11\u20138. https:\/\/doi.org\/10.1080\/09546634.2019.1621981.","journal-title":"J Dermatol Treat"},{"key":"1032_CR27","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.ijwd.2021.02.005","volume":"7","author":"NR Shukla","year":"2021","unstructured":"Shukla NR, Jia JL, Paul M, Kaghazchi A, Linos E, Naik HB. Quality and engagement of online hidradenitis suppurativa information. Int J Womens Dermatol. 2021;7:490\u20131. https:\/\/doi.org\/10.1016\/j.ijwd.2021.02.005.","journal-title":"Int J Womens Dermatol"},{"key":"1032_CR28","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1007\/s13555-022-00701-5","volume":"12","author":"PK Krajewski","year":"2022","unstructured":"Krajewski PK, Marr\u00f3n SE, Tomas Aragones L, Gilaberte-Calzada Y, Szepietowski JC. Self-reported hidradenitis suppurativa severity: is it useful for clinical practice? Dermatol Ther (Heidelb). 2022;12:899\u2013909. https:\/\/doi.org\/10.1007\/s13555-022-00701-5.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1032_CR29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.jaad.2008.11.911","volume":"60","author":"A Alikhan","year":"2009","unstructured":"Alikhan A, Lynch PJ, Eisen DB. Hidradenitis suppurativa: a comprehensive review. J Am Acad Dermatol. 2009;60:539\u201361. https:\/\/doi.org\/10.1016\/j.jaad.2008.11.911.","journal-title":"J Am Acad Dermatol"},{"key":"1032_CR30","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","volume":"144","author":"JM Von Der Werth","year":"2001","unstructured":"Von Der Werth JM, Jemec GBE. Morbidity in patients with hidradenitis suppurativa. Br J Dermatol. 2001;144:809\u201313. https:\/\/doi.org\/10.1046\/j.1365-2133.2001.04137.x.","journal-title":"Br J Dermatol"},{"key":"1032_CR31","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.jaad.2015.07.052","volume":"73","author":"GBE Jemec","year":"2015","unstructured":"Jemec GBE, Kimball AB. Hidradenitis suppurativa: epidemiology and scope of the problem. J Am Acad Dermatol. 2015;73:S4\u20137. https:\/\/doi.org\/10.1016\/j.jaad.2015.07.052.","journal-title":"J Am Acad Dermatol"},{"key":"1032_CR32","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2340\/00015555-1082","volume":"91","author":"S Esmann","year":"2011","unstructured":"Esmann S, Jemec GBE. Psychosocial impact of hidradenitis suppurativa: a qualitative study. Acta Derm Venereol. 2011;91:328\u201332. https:\/\/doi.org\/10.2340\/00015555-1082.","journal-title":"Acta Derm Venereol"},{"key":"1032_CR33","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jaad.2009.09.021","volume":"62","author":"\u0141 Matusiak","year":"2010","unstructured":"Matusiak \u0141, Bieniek A, Szepietowski JC. Hidradenitis suppurativa markedly decreases quality of life and professional activity. J Am Acad Dermatol. 2010;62:706-708.e1. https:\/\/doi.org\/10.1016\/j.jaad.2009.09.021.","journal-title":"J Am Acad Dermatol"},{"key":"1032_CR34","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.jaad.2011.10.024","volume":"67","author":"A Kurek","year":"2012","unstructured":"Kurek A, Peters EMJ, Chanwangpong A, Sabat R, Sterry W, Schneider-Burrus S. Profound disturbances of sexual health in patients with acne inversa. J Am Acad Dermatol. 2012;67:422-428.e1. https:\/\/doi.org\/10.1016\/j.jaad.2011.10.024.","journal-title":"J Am Acad Dermatol"},{"key":"1032_CR35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/j.1468-3083.2012.04468.x","volume":"27","author":"AJ Onderdijk","year":"2012","unstructured":"Onderdijk AJ, van der Zee HH, Esmann S, et al. Depression in patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2012;27:473\u20138. https:\/\/doi.org\/10.1111\/j.1468-3083.2012.04468.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1032_CR36","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s13555-018-0264-z","volume":"8","author":"AB Kimball","year":"2018","unstructured":"Kimball AB, Sundaram M, Gauthier G, et al. The comorbidity burden of hidradenitis suppurativa in the United States: a claims data analysis. Dermatol Ther (Heidelb). 2018;8:557\u201369. https:\/\/doi.org\/10.1007\/s13555-018-0264-z.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1032_CR37","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.12966","volume":"29","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis CC, Desai N, Emtestam L, et al. European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa. J Eur Acad Dermatol Venereol. 2015;29:619\u201344. https:\/\/doi.org\/10.1111\/jdv.12966.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1032_CR38","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1136\/postgradmedj-2013-131994","volume":"90","author":"DN Dufour","year":"2014","unstructured":"Dufour DN, Emtestam L, Jemec GB. Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease. Postgrad Med J. 2014;90:216\u201321. https:\/\/doi.org\/10.1136\/postgradmedj-2013-131994.","journal-title":"Postgrad Med J"},{"key":"1032_CR39","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s13555-020-00354-2","volume":"10","author":"T Tzellos","year":"2020","unstructured":"Tzellos T, Zouboulis CC. Review of comorbidities of hidradenitis suppurativa: implications for daily clinical practice. Dermatol Ther (Heidelb). 2020;10:63\u201371. https:\/\/doi.org\/10.1007\/s13555-020-00354-2.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1032_CR40","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1093\/ced\/llac045","volume":"48","author":"D Mintoff","year":"2023","unstructured":"Mintoff D, Pace NP, Borg I. Management of patients with hidradenitis suppurativa having underlying genetic variation: a systematic review and a call for precision medicine. Clin Exp Dermatol. 2023;48:67\u201372. https:\/\/doi.org\/10.1093\/ced\/llac045.","journal-title":"Clin Exp Dermatol"},{"key":"1032_CR41","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/jdv.13216","volume":"30","author":"AB Kimball","year":"2015","unstructured":"Kimball AB, Sobell JM, Zouboulis CC, et al. HiSCR (hidradenitis suppurativa clinical response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study. J Eur Acad Dermatol Venereol. 2015;30:989\u201394. https:\/\/doi.org\/10.1111\/jdv.13216.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1032_CR42","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/s0190-9622(96)90321-7","volume":"35","author":"GBE Jemec","year":"1996","unstructured":"Jemec GBE, Heidenheim M, Nielsen NH. The prevalence of hidradenitis suppurativa and its potential precursor lesions. J Am Acad Dermatol. 1996;35:191\u20134. https:\/\/doi.org\/10.1016\/s0190-9622(96)90321-7.","journal-title":"J Am Acad Dermatol"},{"key":"1032_CR43","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/bjd.12787","volume":"170","author":"GR Vinding","year":"2014","unstructured":"Vinding GR, Miller IM, Zarchi K, Ibler KS, Ellervik C, Jemec GBE. The prevalence of inverse recurrent suppuration: a population-based study of possible hidradenitis suppurativa. Br J Dermatol. 2014;170:884\u20139. https:\/\/doi.org\/10.1111\/bjd.12787.","journal-title":"Br J Dermatol"},{"key":"1032_CR44","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s13555-022-00872-1","volume":"13","author":"A Garg","year":"2023","unstructured":"Garg A, Naik HB, Alavi A, et al. Real-world findings on the characteristics and treatment exposures of patients with hidradenitis suppurativa from US claims data. Dermatol Ther (Heidelb). 2023;13:581\u201394. https:\/\/doi.org\/10.1007\/s13555-022-00872-1.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1032_CR45","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1159\/000503605","volume":"237","author":"AJ Hendricks","year":"2021","unstructured":"Hendricks AJ, Hsiao JL, Lowes MA, Shi VY. A comparison of international management guidelines for hidradenitis suppurativa. Dermatology. 2021;237:81\u201396. https:\/\/doi.org\/10.1159\/000503605.","journal-title":"Dermatology"},{"key":"1032_CR46","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/j.1468-3083.2009.03356.x","volume":"23","author":"J Revuz","year":"2009","unstructured":"Revuz J. Hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2009;23:985\u201398. https:\/\/doi.org\/10.1111\/j.1468-3083.2009.03356.x.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1032_CR47","doi-asserted-by":"publisher","first-page":"e069206","DOI":"10.1136\/bmjopen-2022-069206","volume":"13","author":"M Alwhaibi","year":"2023","unstructured":"Alwhaibi M, Malik SB, Alswailem L, Alruthia Y. Self-medication among adults with chronic health conditions: a population-based cross-sectional survey in Saudi Arabia. BMJ Open. 2023;13:e069206. https:\/\/doi.org\/10.1136\/bmjopen-2022-069206.","journal-title":"BMJ Open"},{"key":"1032_CR48","doi-asserted-by":"publisher","first-page":"421","DOI":"10.5114\/ada.2020.92570","volume":"38","author":"A Wnuk-K\u0142osi\u0144ska","year":"2021","unstructured":"Wnuk-K\u0142osi\u0144ska A, Bielanowska E, Adamski Z, Czajkowski R, Jenerowicz D. The use of complementary and alternative medicine by patients suffering from psoriasis and psoriatic arthritis. Adv Dermatol Allergol. 2021;38:421\u20136. https:\/\/doi.org\/10.5114\/ada.2020.92570.","journal-title":"Adv Dermatol Allergol"},{"key":"1032_CR49","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s40257-014-0105-5","volume":"16","author":"A Alavi","year":"2014","unstructured":"Alavi A, Anooshirvani N, Kim WB, Coutts P, Sibbald RG. Quality-of-life impairment in patients with hidradenitis suppurativa: a Canadian study. Am J Clin Dermatol. 2014;16:61\u20135. https:\/\/doi.org\/10.1007\/s40257-014-0105-5.","journal-title":"Am J Clin Dermatol"},{"key":"1032_CR50","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s13555-020-00391-x","volume":"10","author":"DK Saylor","year":"2020","unstructured":"Saylor DK, Brownstone ND, Naik HB. Office-Based surgical intervention for hidradenitis suppurativa (HS): a focused review for dermatologists. Dermatol Ther (Heidelb). 2020;10:529\u201349. https:\/\/doi.org\/10.1007\/s13555-020-00391-x.","journal-title":"Dermatol Ther (Heidelb)"},{"key":"1032_CR51","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1111\/j.1365-2702.2010.03498.x","volume":"20","author":"AD Akyol","year":"2011","unstructured":"Akyol AD, Yildirim Y, Toker E, Yavuz B. The use of complementary and alternative medicine among chronic renal failure patients. J Clin Nurs. 2011;20:1035\u201343. https:\/\/doi.org\/10.1111\/j.1365-2702.2010.03498.x.","journal-title":"J Clin Nurs"},{"key":"1032_CR52","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1080\/09546634.2017.1395806","volume":"29","author":"M Maarouf","year":"2017","unstructured":"Maarouf M, Clark AK, Lee DE, Shi VY. Targeted treatments for hidradenitis suppurativa: a review of the current literature and ongoing clinical trials. J Dermatol Treat. 2017;29:441\u20139. https:\/\/doi.org\/10.1080\/09546634.2017.1395806.","journal-title":"J Dermatol Treat"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-01032-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-023-01032-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-01032-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T06:12:59Z","timestamp":1698473579000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-023-01032-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":52,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["1032"],"URL":"https:\/\/doi.org\/10.1007\/s13555-023-01032-9","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,4]]},"assertion":[{"value":"21 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Andr\u00e9 Vicente Esteves de Carvalho, Danilo Hamilko de Barros, Gleison Vieira Duarte, Roberto Souto da Silva, Renata Ferreira Magalh\u00e3es, and Wagner Guimar\u00e3es Galv\u00e3o Cesar have received grants, consulting fees, or speaking honoraria from companies, including but not limited to AbbVie, Amgen, Bayer, Biolab, Boehringer Ingelheim, Eli-Lilly, Galderma, Janssen, Leo Pharma, Novartis, Pfizer, Sandoz, Sanofi, or UCB. Ericles Andrei Bellei, Beatriz Magalh\u00e3es Eng, Carla Tozato, Erika Yumi Tamashiro, Rafael Toledo Rodrigues de F\u00e1tima, and Felipe Garutti Thies are employed by Novartis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All the data collected, analyzed, and presented in this study were exclusively sourced from public and openly accessible platforms. All the narratives collected were anonymized prior to any analysis. This article underwent review by the scientific committee of Novartis (code CLR-12165\/AIN-MS-117664) and was approved for publication without requiring any additional review by an ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}